Purchases and Sales Made in Q3 2024 in Biomarin Pharmaceutical Inc (BMRN)
This table provides information about the institutional ownership of Biomarin Pharmaceutical Inc (BMRN) during Q3 2024. The information is specifically focused on institutions that hold shares of BIOMARIN PHARMACEUTICAL INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Oct 25, 2024
Q3 2024
|
Fort Washington Investment Advisors Inc
|
SELL
|
- |
-251K- 25.64% |
$17.3M - $23.6M
|
728K
$48.5M
|
|
|
Nov 13, 2024
Q3 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-261K- 14.44% |
$18M - $24.5M
|
1.55M
$103M
|
|
|
Nov 14, 2024
Q3 2024
|
Apg Asset Management N.V.
Amsterdam, P7 |
SELL
|
- |
-316K- 94.23% |
$21.8M - $29.6M
|
19.3K
$1.29M
|
|
|
Nov 14, 2024
Q3 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-320K- 32.52% |
$22.1M - $30M
|
664K
$44.2M
|
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-327K- 27.29% |
$22.5M - $30.6M
|
870K
$58M
|
|
|
Nov 12, 2024
Q3 2024
|
Northwestern Mutual Wealth Management CO
|
SELL
|
- |
-380K- 96.32% |
$26.3M - $35.7M
|
14.5K
$968K
|
|
|
Nov 08, 2024
Q3 2024
|
Bnp Paribas Asset Management Holding S.A.
|
SELL
|
- |
-391K- 71.72% |
$27M - $36.7M
|
154K
$10.3M
|
|
|
Nov 14, 2024
Q3 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-420K- 8.93% |
$29M - $39.4M
|
4.28M
$285M
|
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-476K- 42.55% |
$32.9M - $44.7M
|
643K
$42.8M
|
|
|
Nov 12, 2024
Q3 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-744K- 44.71% |
$51.3M - $69.8M
|
920K
$61.3M
|
|
|
Nov 14, 2024
Q3 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-813K- 8.44% |
$56.1M - $76.3M
|
8.82M
$588M
|
|
|
Nov 15, 2024
Q3 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-831K- 74.29% |
$57.3M - $78M
|
288K
$19.2M
|
|
|
Nov 14, 2024
Q3 2024
|
Avoro Capital Advisors LLC
New York, NY |
SELL
|
- |
-2.52M- 55.28% |
$174M - $236M
|
2.04M
$136M
|